Prevalence of human papillomavirus infection in a Kashmiri ethnic female population

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 8, 2012, Pages 904-909

  Asiaf, Asia ^a   Ahmad, Shiekh Tanveer ^b   Zargar, Muhammad Afzal ^a   Mufti, Shahida Masarat ^c   Mir, Syed Hussain ^a  

^a UNIVERSITY OF KASHMIR   (India)

^b HAMDARD UNIVERSITY   (India)

^c GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER RISK; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GROUPS BY AGE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INDIA; MAJOR CLINICAL STUDY; MARRIAGE; PAPILLOMAVIRUS INFECTION; PARITY; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SENSITIVITY ANALYSIS; SEXUAL BEHAVIOR; SOCIAL STATUS; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS GENOME;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; BASE SEQUENCE; DNA PRIMERS; ETHNIC GROUPS; FEMALE; HUMANS; INDIA; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84865699241     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0354     Document Type: Article

References (32)

1. Appleby P, Beral V (2007) GA Berrington de et al., Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16, 573 women with cervical cancer and 35, 509 women without cervical cancer from 24 epidemiological studies. Lancet 370:1609-1621.
2. Bosch FX, De Sanjosé S (2003) Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 31:3-13.
3. Bosch FX, Manos MM, Muñoz N, et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87:796-802.
4. Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1-17.
5. Carvalho NO, Del Castillo DM, Perone C, et al. (2010) Comparison of HPV genotyping by type-specific PCR and sequencing. Mem Inst Oswaldo Cruz 105:73-78.
6. de Roda Husman AM, Walboomers JMM, van den Brule AJC, et al. (1995) The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062.
7. de Villiers EM, Gunst K, Stein H, Scherübl H (2004) Esophageal squamous cell cancer in patients with head and neck cancer: prevalence of human papillomavirus DNA sequences. Int J Cancer 109:253-258.
8. Duttagupta C, Sengupta S, Roy M, et al. (2004) Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India. Int J Gynecol Cancer 14:293-303.
9. Ferreccio C, Prado RB, Luzoro AV, et al. (2004) Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 13:2271.
10. Franceschi S, Rajkumar R, Snijders PJF, et al. (2005) Papillomavirus infection in rural women in southern India. Br J Cancer 92:601-606.
11. Franceschi S, Rajkumar T, Vaccarella S, et al. (2003) Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case control study. Int J Cancer 107:127-133.
12. Frazer IH (2009) Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology 384:410-414.
13. Hamkar R, Mokhtari-Azad T, Mahmoodi M, et al. (2002) Prevalence of various types of Human Papillomavirus among cervical cancer and normal biopsy specimens in the Mazandaran province of Iran. Eastern Mediterr Health J 6:805-811.
14. Herrero R, Hildesheim A, Bratti C, et al. (2000) Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92:464.
15. Jastreboff AM, Cymet T (2002) Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J 78:225.
16. Kitchener HC, Symonds P (1999) Detection of cervical intraepithelial neoplasia in developing countries. Lancet 353:856.
17. Kotloff KL, Wasserman SS, Russ K, et al. (1998) Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis 25:243-250.
18. Lazcano Ponce E, Herrero R, Munoz N, et al. (2001). Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 91:412-420.
19. Manos MM, Ting Y, Wright DK, et al. (1989) Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer cells 7:209-214.
20. Matsumoto K (2007) Human papillomavirus and cervical cancer. Nihon Rinsho 65:2113-2124.
21. Meijer CJ, Snijders PJ, Castle PE (2006) Clinical utility of HPV genotyping. Gynecol Oncol 103:12-17.
22. Molano M, Posso H, Weiderpass E, et al. (2002) Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 87:324-333.
23. *. Lancet 359:1093-1101.
24. Payal R, Gupta S, Aggarwal R, et al. (2006) Detection of high-risk human papillomavirus type 16/18 in cutaneous warts in immunocompetent patients, using polymerase chain reaction. J Dermatol online 12:1.
25. Rama CH, Roteli-Martins CM, Derchain SFM, et al. (2008) Prevalence of genital HPV infection among women screened for cervical cancer. Rev Saúde Pública 42:123-130.
26. Sankaranarayanan R, Budukh AM, Rajkumar R (2001) Effective screening programmes for cervical cancer in low-and middleincome developing countries. Bull World Health Organ 79:954-962.
27. Shikova E, Todorova I, Ganchev G, Kouseva-Dragneva V (2009) Detection and typing of human papillomaviruses by PCR. Biotechnology & Biotechnological Equipment 23:877-880.
28. Smith JS, Bosetti C, Munoz N, et al. (2004) IARC Multi-centric Cervical Cancer Study Group. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 111:431-439.
29. Stanley M (2003) Genital human papillomavirus infectionscurrent and prospective therapies. J Natl Cancer Inst Monogr 117-124.
30. Thomas JO, Herrero R, Omigbodun AA, et al. (2004) Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 90:638-645.
31. Walboomers JMM, Jacobs MV, Manos MM, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
32. Zur Hausen H (1996) Papillomavirus infections-a major cause of human cancers. Biochim Biophy Acta (BBA)-Rev Cancer 1288:F55-F78.